Literature DB >> 22072810

Bench to bedside and back again: personalizing treatment for patients with GIST.

Andrew K Godwin1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22072810      PMCID： PMC4007578          DOI： 10.1158/1535-7163.MCT-11-0709

Source DB:  PubMed          Journal:  Mol Cancer Ther        ISSN： 1535-7163            Impact factor:   6.261


× No keyword cloud information.
  9 in total

1.  Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors.

Authors:  S Hirota; K Isozaki; Y Moriyama; K Hashimoto; T Nishida; S Ishiguro; K Kawano; M Hanada; A Kurata; M Takeda; G Muhammad Tunio; Y Matsuzawa; Y Kanakura; Y Shinomura; Y Kitamura
Journal:  Science       Date:  1998-01-23       Impact factor: 47.728

2.  Therapeutic effect of imatinib in gastrointestinal stromal tumors: AKT signaling dependent and independent mechanisms.

Authors:  Chi Tarn; Yuliya V Skorobogatko; Takahiro Taguchi; Burton Eisenberg; Margaret von Mehren; Andrew K Godwin
Journal:  Cancer Res       Date:  2006-05-15       Impact factor: 12.701

Review 3.  The insulin-like growth factor system as a potential therapeutic target in gastrointestinal stromal tumors.

Authors:  Martin G Belinsky; Lori Rink; Kathy Q Cai; Michael F Ochs; Burton Eisenberg; Min Huang; Margaret von Mehren; Andrew K Godwin
Journal:  Cell Cycle       Date:  2008-10-07       Impact factor: 4.534

4.  Detection of treatment-induced changes in signaling pathways in gastrointestinal stromal tumors using transcriptomic data.

Authors:  Michael F Ochs; Lori Rink; Chi Tarn; Sarah Mburu; Takahiro Taguchi; Burton Eisenberg; Andrew K Godwin
Journal:  Cancer Res       Date:  2009-11-10       Impact factor: 12.701

5.  Response markers and the molecular mechanisms of action of Gleevec in gastrointestinal stromal tumors.

Authors:  Andrey Frolov; Santiago Chahwan; Michael Ochs; Juan Pablo Arnoletti; Zhong-Zong Pan; Olga Favorova; Jonathan Fletcher; Margaret von Mehren; Burton Eisenberg; Andrew K Godwin
Journal:  Mol Cancer Ther       Date:  2003-08       Impact factor: 6.261

Review 6.  Clinical and molecular characteristics of gastrointestinal stromal tumors in the pediatric and young adult population.

Authors:  Lori Rink; Andrew K Godwin
Journal:  Curr Oncol Rep       Date:  2009-07       Impact factor: 5.075

7.  Gene expression signatures and response to imatinib mesylate in gastrointestinal stromal tumor.

Authors:  Lori Rink; Yuliya Skorobogatko; Andrew V Kossenkov; Martin G Belinsky; Thomas Pajak; Michael C Heinrich; Charles D Blanke; Margaret von Mehren; Michael F Ochs; Burton Eisenberg; Andrew K Godwin
Journal:  Mol Cancer Ther       Date:  2009-08-11       Impact factor: 6.261

8.  High density DNA array analysis reveals distinct genomic profiles in a subset of gastrointestinal stromal tumors.

Authors:  Martin G Belinsky; Yuliya V Skorobogatko; Lori Rink; Jianming Pei; Kathy Q Cai; Lisa A Vanderveer; David Riddell; Erin Merkel; Chi Tarn; Burton L Eisenberg; Margaret von Mehren; Joseph R Testa; Andrew K Godwin
Journal:  Genes Chromosomes Cancer       Date:  2009-10       Impact factor: 5.006

9.  Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumors.

Authors:  Chi Tarn; Lori Rink; Erin Merkel; Douglas Flieder; Harsh Pathak; Daphne Koumbi; Joseph R Testa; Burton Eisenberg; Margaret von Mehren; Andrew K Godwin
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-11       Impact factor: 11.205
  9 in total
  4 in total

1.  Drug repurposing for gastrointestinal stromal tumor.

Authors:  Ziyan Y Pessetto; Scott J Weir; Geetika Sethi; Melinda A Broward; Andrew K Godwin
Journal:  Mol Cancer Ther       Date:  2013-05-08       Impact factor: 6.261

2.  Drug repurposing identifies a synergistic combination therapy with imatinib mesylate for gastrointestinal stromal tumor.

Authors:  Ziyan Y Pessetto; Yan Ma; Jeff J Hirst; Margaret von Mehren; Scott J Weir; Andrew K Godwin
Journal:  Mol Cancer Ther       Date:  2014-08-13       Impact factor: 6.261

3.  Insights into the Proteome of Gastrointestinal Stromal Tumors-Derived Exosomes Reveals New Potential Diagnostic Biomarkers.

Authors:  Safinur Atay; Daniel W Wilkey; Mohammed Milhem; Michael Merchant; Andrew K Godwin
Journal:  Mol Cell Proteomics       Date:  2017-12-14       Impact factor: 5.911

4.  Oncogenic KIT-containing exosomes increase gastrointestinal stromal tumor cell invasion.

Authors:  Safinur Atay; Samagya Banskota; Jennifer Crow; Geetika Sethi; Lori Rink; Andrew K Godwin
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-30       Impact factor: 11.205
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.